Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Greenwich LifeSciences, Inc. (GLSI) had Pre-Tax Income of $-19.36M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.36M |
|
-- |
|
-- |
|
$19.45M |
|
$-19.45M |
|
$0.09M |
|
|
Pre-Tax Income |
$-19.36M |
$-19.36M |
|
$-19.36M |
|
$-19.36M |
|
$-19.36M |
|
$-19.36M |
|
$-19.45M |
|
$-19.45M |
|
13.54M |
|
13.54M |
|
$-1.43 |
|
$-1.43 |
|
| Balance Sheet Financials | |
$6.18M |
|
-- |
|
-- |
|
$6.18M |
|
$5.82M |
|
-- |
|
-- |
|
$5.82M |
|
$0.35M |
|
$0.35M |
|
$0.35M |
|
14.30M |
|
| Cash Flow Statement Financials | |
$-9.91M |
|
-- |
|
$12.00M |
|
$4.09M |
|
$6.18M |
|
$2.09M |
|
$6.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5480.65% |
|
-5480.54% |
|
-313.34% |
|
-5480.55% |
|
$0.02 |
|
$-0.73 |
|
$-0.73 |
|